The invention relates to a compound of a general formula (I): wherein Ar1 representsa group formed from an aromatic ring selected from a group consisting of benzene,pyrazole, isoxazole, pyridine, indole, 1H-indazole, 1H-furo[2,3-c]pyrazole,1H-thieno[2,3-c]pyrazole, benzimidazole, 1,2-benzisoxazole, imidazo[1,2-a]pyridine,imidazo[1,5-a]pyridine and 1H-pyrazolo[3,4-b]pyridine, having Ar2, andoptionally having one or two or more substituents selected from R3； R1 and R2 eachindependently represent a hydrogen atom, a halogen atom, a cyano group, a C2-C6alkenyl group, a C1-C6 alkoxy group, a C2-C7 alkanoyl group, a C2-C7 alkoxycarbonylgroup, an aralkyloxycarbonyl group, a carbamoyl-C1-C6 alkoxy group, a carboxy-C2-C6alkenyl group, or a group of -Q1-N(Ra)-Q2-Rb； or a C1-C6 alkyl group optionallyhaving a substituent； or an aryl or heterocyclic group optionally having a substituent；or a C1-C6 alkyl group or a C2-C6 alkenyl group having the aryl or heterocyclicgroup； T and U each independently represent a nitrogen atom or a methine group；and V represents an oxygen atom or a sulfur atom. The compound of the inventionis useful as therapeutical agents for various ACC-related diseases.
